While the role of microflora is well established in the development of inflammatory bowel disease (IBS); data is still emerging regarding IBS as the knowledge on brain-gut interaction grows. For both patient groups multiple efficacious treatments exist, but there are still unmet needs as long term disease control remains an issue. Given the importance of the microbiome on the development of the immune system and the interaction between the microbiome and the host organism, this "route" is being examined increasingly as a therapeutic possibility in both pathologies with variable Results: We here provide a short overview on the existing data, meta-analysis and single studies, on probiotic treatment in both diseases. Copyright © 1996-2014;.
Originele taal-2English
TitelMinerva Pediatrica
UitgeverijEdizioni Minerva Medica S.p.A.
Aantal pagina's10
ISBN van geprinte versie0026-4946 (Print)\r0026-4946
StatusPublished - 1 okt 2014

Publicatie series

NaamMinerva Pediatrica


Duik in de onderzoeksthema's van 'The use of probiotics in IBD and IBS'. Samen vormen ze een unieke vingerafdruk.

Citeer dit